Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.76	36.41	47.14
Graham Fair Price	-24.79	11.02	14.65
PEG	205.66	5.41	1.77
Price/Book	-16.74	0.93	1.11
Price/Cash Flow	14277.20	1377.79	-9.58
Prices/Earnings	-49.96	-240.82	-160.59
Price/Sales	-22.88	1.87	2.42
Price/FCF	14277.20	1377.79	-9.58
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-39.37	0.09	0.15
Operating Margin	36.77	0.04	0.03
ROA	44.77	< 0.005	< 0.005
ROE	< 0.005	< 0.005	44.48
ROIC	< 0.005	< 0.005	-18.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	52.50
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	2.09	0.47	-77.51
EPS QOQ	0.91	0.45	-50.94
FCF QOQ	0.23	1.01	346.77
Revenue QOQ	0.08	0.07	-7.95
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.28	5.39	-14.15
Days Sales Outstanding (DSO)	10.42	9.94	-4.61
Inventory Turnover	14.32	16.69	16.48
Debt/Capitalization	0.58	0.63	8.57
Quick Ratio	0.74	0.68	-8.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	74.16	74.85	0.93
Cash	46.39	46.80	0.90
Capex	-11.61	-9.45	18.64
Free Cash Flow	-8.62	0.05	-99.42
Revenue	34.11	37.16	8.96
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.76	-7.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.20	23.14	-17.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating